Leave a Reply

986 Comments on "Comments"

Notify of
Sort by:   newest | oldest | most voted
baz22
Member
Anything is possible, but some indications from the Mayo Clinic involving Geron’s Imetelstat trials, although not applicable to all patients, are beyond what any currently marketed drug is doing. Talking complete response and normal bone marrow ( which is unheard of ). Do not have patient percentage specifics, but this is based on the ‘ starter dose ‘.. If ever FDA approved, and safety, efficacy and tolerance levels are defined, imagine the possible results. Sarepta is in the same situation, because when their PPMO program is clinically validated and eventually replaces the PMO program, dreams really may come true. Certainly… Read more »
skyler
Member

biotechs (ibb) having a great week. healthcare (iyh) as well. anyway bought USO for at least a bounce? was watching aray since early June for a pullback, then i missed it. . . ‘slow learner’ but learning.

Kyle
Member

JimG — Thanks for posting the Bradley Siderograph chart. Really do believe there is SOME element of Truth in All these different approaches. NO Single approach has the complete answer — NOT EW, nor Fib, nor VP/MP, nor Gann, BUT there are components of each.

Kyle
Member

$CL_F
https://twitter.com/Nouf_wpt/with_replies
Wavepatterntraders‏ @Nouf_wpt
$CL_F Perfect area to end a decline, 1×1 target hit from 54.61 also can end a large WXY correction from Jan 17 highs

$CL_F Bulls need a big move back above 44.00. then 45.31 to kick in a squeeze

Kyle
Member

I Just Love Sarcasm & British Humor …

https://twitter.com/Trader_Dante/with_replies
Tom Dante‏ @Trader_Dante
Have you ever wondered what its like to be a professional trader?
Tom Dante‏ @Trader_Dante
Sit and stare at 6 screens for 10 hours, then freebase some coke and burn $1k cash.

baz22
Member

I believe the strong move by Bellicum ( blcm ) over the past week is tied not so much to their outstanding T-cell work ( TCR and CAR-T ) but to the possibility of a really good partnership deal with perhaps BIIB or Roche, even Genentech or Celgene. Being that they are just in Phase 1/2 into 1a, they will need additional funding sometime in late 2018. This makes financial sense. Haven’t sold a single share… Best to all..

Kyle
Member

$CL_F
https://stocktwits.com/TheFibDoctor
TheFibDoctor
$CL_F Daily chart. Solid rejection at 1st resistance of 44.11. (high = 44.2)

https://charts.stocktwits.com/production/original_86582423.?1498057764

Kyle
Member
JimG
Member

Oil Futures Contracts. Is the fire sale over?

https://twitter.com/jmanfreddi/status/877524091925925889

JimG
Member
JimG
Member

Today is a Bradley Siderograph turn date for crude oil

http://imgur.com/a/wCnJk

johnuk
Member

Good point Kyle.”trade reversals on the RHS Not on the LHS.” The difficult part is knowing when your on the RHS.

johnuk
Member

Quote.
“British built car rated most reliable – with EIGHT German cars branded as worst clunkers.”
( Mar2015.)

http://www.express.co.uk/news/uk/565314/British-built-car-reliable-German-clunkers

johnuk
Member

Lufthansa, only airline that’s left me in the lurch because of a pilots strike. Not impressed with Star Alliance members.

Kyle
Member

StockCats‏ @StockCats Jun 19
if the Fed keeps raising rates into weak economic data as the war in Syria heats up, there’s no telling how high this market might go

Carl Lantz‏ @CarlLantz
If nuclear war breaks out, make sure to buy the first 10 handle dip in ES before seeking shelter.

Grasshopper
Member

Hey Bill – Would you mind sharing any of the small cap names that you feel impatient traders have been dumping unnecessarily ? I did a search on Finviz for small cap Oilers and couldn’t find any that were holding a lot of cash and were profitable. I own the following small cap oilers (ECR, EPE, KOS, BTE and DNR) but would love to know which, if any of these you like or don’t like. Thanks!

wpDiscuz

Disclaimer: billcara.com is a website published by Greenfield Capital Inc and neither Greenfield Capital nor billcara.com is a registered broker-dealer or a registered investment adviser. You understand that this web site and its content is furnished for non-commercial, informational purposes only, and that no mention of a particular security in this website constitutes a recommendation to buy, sell, or hold that or any other security, nor any particular portfolio of securities, transaction or investment strategy as suitable for any specific person. Information regarding trading and investment as provided by this website is not tailored to the investment needs of any specific person. Greenfield Capital and billcara.com services will not advise you personally concerning the nature, potential, value or suitability of any particular security, securities portfolio, transaction or other matter. You acknowledge that you are responsible for your own financial decisions and should seek a registered agent depending on your own risk tolerance to advise you on your personal trading activities.